Register      Login
Journal of Primary Health Care Journal of Primary Health Care Society
Journal of The Royal New Zealand College of General Practitioners
RESEARCH ARTICLE (Open Access)

Prescribing deprescribing for polypharmacy in Aotearoa New Zealand; experiences of a medication review activity in final year medical students on a general practice module

Samantha A. Murton https://orcid.org/0000-0002-0150-5567 1 * , Lynn McBain https://orcid.org/0000-0002-9177-5172 1 , Caroline Morris https://orcid.org/0000-0002-8751-0657 1 , Estelle Jaine 1 , Lesley Gray https://orcid.org/0000-0001-6414-3236 1
+ Author Affiliations
- Author Affiliations

1 University of Otago, Wellington, Department of Primary Health Care and General Practice, Te Whare Wānanga o Otāgo ki Te Whanga-Nui-a-Tara, 6242, New Zealand/Aotearoa.

* Correspondence to: samantha.murton@otago.ac.nz

Handling Editor: Tim Stokes

Journal of Primary Health Care https://doi.org/10.1071/HC23169
Submitted: 14 December 2023  Accepted: 20 May 2024  Published: 7 June 2024

© 2024 The Author(s) (or their employer(s)). Published by CSIRO Publishing on behalf of The Royal New Zealand College of General Practitioners. This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND)

Abstract

Introduction

This study explored the experiences of students and their supervisors undertaking a medication review activity during a 6-week general practice module in their final year of medical school at University of Otago, Wellington, Aotearoa New Zealand.

Aim

The study sought the self-reported value of the activity in learning about prescribing, reflecting on polypharmacy, deprescribing, and changes to future practice for both student and supervisor.

Methods

All students in the final year general practice module were invited to complete a survey over a 12-month period, as were their supervisors. An abductive thematic analysis of survey results was performed.

Results

Fifty-eight percent (48/87) of students and 30% (10/33) of supervisors completed surveys. Five themes were identified in the analysis of qualitative data: value of the medication review, complexities of medicines, importance of monitoring, value of resources, and supervisor reflections on value to the student. Student and supervisor responses reflected on prescribing practice beyond what medication to give when. All responses described benefit to patients and the majority expressed thoughts on how it would change their future prescribing.

Discussion

The medication review activity in the final year general practice module provides learning opportunities for both student and general practitioner supervisor. This activity emphasises the risks of polypharmacy and how to deprescribe. This study underlines the value of medication reviews as intraprofessional communication activities, allowing reflection beyond what medication to prescribe and for what condition. The results underline the importance of reflecting on practice and aids quality improvement benefit to patients.

Keywords: clinical practice, deprescribing, medication review, medications, polypharmacy, prescription medicines, professional education, reflective practice, risk management.

WHAT GAP THIS FILLS
What is already known: Polypharmacy is increasing as the population ages and causes harm. Deprescribing takes time and requires thoughtful consideration and patient interaction.
What this study adds: Focused deprescribing is a significant reflective learning and quality improvement opportunity for medical students and general practitioner supervisors. This student-led activity adds benefit to the student, their supervisor, and the patient of a comprehensive medications review leading to improved knowledge, appropriate deprescribing, and reduced drug interactions.

Introduction

Prescribing is a core activity in any medical profession,1,2 and is a cause of many harms38 if not done with caution. Polypharmacy is particularly harmful due to the increased potential for drug interactions and adverse drug effects, highlighted by the World Health Organization initiative as part of their Global Patient Safety Challenge: Medication Without Harm.9 A prescribing cascade frequently occurs when medications are added to counter the adverse effects of others. These additional drugs also have potential for adverse effects. Problematic polypharmacy may be defined as:

the prescribing of multiple medications inappropriately or where the intended benefit of the medication is not realised.8

Problematic polypharmacy is a significant global issue for patients, practitioners, and the health sector.10,11 A 2019 study9 found increasing polypharmacy with an increase in age (these findings are summarised in Table 1). People on multiple medications are more likely to be admitted to hospital than someone who is prescribed one to three medicines a day. Furthermore, the frequency of adverse reactions can increase, with 82% of those on seven or more medicines reporting an adverse reaction.12

Table 1.People aged 65 and over receiving five or more long-term medicines, by age in New Zealand, 2019.

Age (%)
65–74 years75–84 years85 years and over
Dispensed 5 or more long-term medicines23.139.151.6
5–7 long-term medicines14.622.828.7
8–10 long-term medicines5.911.216.3
11 or more long-term medicines2.75.16.7

In Aotearoa New Zealand (NZ), 4% of people over the age of 65 years are dispensed 11 or more medications.1 In general practice, polypharmacy and repeat prescribing without patient review are common and raise concerns over safety issues.4,13 Medication review for deprescribing is more time consuming for patients and medical practitioners than simply repeating the current list and can be costly for patients in terms of appointment costs.

Training programmes are part of the suggested solution for reducing harms and waste from polypharmacy.14 Learning to prescribe during medical training at the University of Otago happens across all years of the medical degree.15 Students do not write prescriptions without supervision, and junior doctors continue supervised prescribing until they have completed their first post-graduate year. Learning ‘good prescribing’,3 reviewing medications and deprescribing are core skills of a prescriber.

Teaching is commonly focused on single organ systems and may not take into consideration the multi-morbid patient. One learning opportunity that most closely reflects the care of a multi-morbid patient is the regular prescribing that occurs in a general practice setting. In the geographical regions where students undertake their general practice module with the University of Otago, the corresponding problematic polypharmacy rates range from 2.6 to 4.5%.16

This study aimed to explore the value of student and general practitioner (GP) supervisor experiences with the medication review activity undertaken during the general practice module in the final year of medical school. In addition, it looked to ascertain if the volume of work was seen to provide valuable learning and benefit to their future prescribing practice.

Method

The medication review scholarship and assessment activity was introduced into the University of Otago, Wellington campus in 2015 by the Convenor for the general practice module (LG) and the then Undergraduate Director (LMcB). It is a compulsory assessed item that contributes to the final mark for the general practice module and highlights the issues around polypharmacy to students. The assessment is marked by tutors in the Department of Primary Health Care and General Practice (see Supplementary File S1). Tutor marking and written feedback is provided to the student. A small proportion of reviews are returned to the student when further detail is required in the template, often this is because information around social context is omitted or very brief.

In 2018, GP supervisors were presented with some of the completed medication reviews at regional workshops to give them examples of what a high-calibre medication review looked like. These workshops involved a small group activity reflecting on medication reviews that had been marked as resubmit, pass, or excellent. Time was allowed for discussion of how a medication review completed by students might provide value for both patients and GP supervisors. Reflections from the workshops about the time taken to complete a comprehensive medication review was one of the drivers for conducting this study. The Convenors for the programme in 2018 (SM and LG) agreed that a review of experiences from both students and supervisors would provide evidence to support the proposed value of the activity.

Participants comprised final year medical students at the University of Otago, Wellington during their 6-week clinical general practice module (approximately 100 per year) and GP supervisors from general practices. The Primary Health Care and General Practice (PHC&GP) Department contracts with 30–40 practices in the lower North Island each year. Each 6-week module has between 12 and 15 students, with each student placed individually in a practice, with a nominated GP supervisor overseeing their learning experiences. GP supervisors will usually have between 3 and 8 students per year.

In the first few weeks of their general practice module, the students are required to ask their GP supervisor to identify a suitable patient for polypharmacy medication review. Students are expected to see the patient or have sufficient information to conduct a desk-based review and then write up the regular medication chart. Reflection on options for changes to the patient’s current medication regime using evidence-based resources such as Health Pathways (https://3d.communityhealthpathways.org/), The New Zealand Formulary (NZF),17 Best Practice Advisory Centre18 and discussion with others eg pharmacist, nurses, and whānau (patient family) is part of the review assignment. On completion of the medication review, the student then discusses the result and their recommendations for change with their GP supervisor. Students write a reflection on this discussion and hand the work in for marking. The medication review is marked independently by a practising GP or GP lecturer within the department and, at the time of this study, these were returned with marker comments to both the student and the GP supervisor. Some students were asked to resubmit their medication review if it did not meet the required standard. This often entailed improved social history, details of prescribing interactions, or a more detailed self-reflection.

Clear instructions for the medication review were available for students on their web-based learning platform (MedMoodle) including a template to provide guidance and consistency (Supplementary File S1).

Between November 2019 and October 2020, all final year medical students undertaking a medication review on their 6-week general practice module were emailed a study survey (Supplementary File S2). A repeat request for completion was sent out a week later. From the end of June 2020, a similar survey (Supplementary File S2) was sent out to the GPs supervising the students during the study period. A second request for completion was also sent out to the supervisors a week later.

Ethics

Ethical approval for this research was obtained from the University of Otago, Human Ethics committee (reference: HD19/284).

Data analysis

Survey results were collated through the Qualtrix XM© online survey platform (Qualtrics.com). Qualitative and quantitative data were analysed using abductive thematic analysis.19 Abductive thematic analysis involved one author’s familiarisation and coding of data before grouping into themes (SM). Themes were then cross-checked and refined with two co-authors (LG and CM) before theorisation and comparison across data sets for students and supervisors.

Results

Between November 2019 and October 2020, 106 students were eligible for the final year general practice module. Of those, seven students were assigned to an interprofessional education programme and were not required to complete the medication review. Twelve students were affected by COVID-19 lockdown issues and did not complete a general practice module. Eighty-seven students completed a medication review and were eligible to participate in this research. The survey was completed by 48 (55%) students (Fig. 1). Students were placed across 33 practices during that time. Surveys were sent to GP supervisors from June 2020 to October 2020 and 10 (30%) supervisors completed the survey. Fig. 1 shows a flow diagram of student participation.

Fig. 1.

Flow chart of student participants.


HC23169_F1.gif

Time spent on the medication review

The majority of students (32/48, 67%) spent 3–6 h on the medication review. Ten students (21%) spent between 1 and 3 h on the review and six students (12%) spent more than 6 h. GP supervisors indicated that the time spent with the student reflecting on the medication review ranged between 15 and 60 min. Neither students nor GP supervisors made any negative comment about the time taken or reflected that the medication review was a burden on their role in the activity.

Thematic analysis

Five themes were identified in the analysis of qualitative data: value of the medication review; complexity of prescribing; importance of monitoring; value of resources; and supervisor reflections on value to the student.

Value of the medication review

All the GP supervisors and 46 (96%) students commented that a medication review adds value for the patient. The themes around the value of the review that emerged from students and supervisors were comprehensiveness of the review, safety aspects, better treatment could be achieved, gave a chance to explore the patient experience, saved time for the GP supervisor, had psychological benefit for the patient, and was a chance to reduce medications.

Excellent value. For one patient in recent years, I remember it significantly improved their Quality of Life. (GP Supervisor 2)

My patient was very, very grateful for the opportunity to do such a comprehensive review. I think the benefits for him were that he better understood his medications, felt empowered about what he was on and how he was taking them bc [because] it really had been shared decision making and his concerns had been heard and acted on. My med review resulted in a lot of changes and updated monitoring, so I think it improved patient safety and helped to get things up to date for this patient for the GP. (Student 46)

Seven students commented on the essential nature of a medication review and that it was important for monitoring, discussing lifestyle issues, and picking up on the use of over-the-counter medications.

I learnt how to treat according to the patient’s lifestyle and needs and learned how to align with patient centred care, focus on their priorities. Slight tweaks can make a lot of difference. (Student 27)

A few students commented that they thought the process helped their GP supervisor as well as the patient.

high value for [patient], I believe quite often no one has done a thorough review of all the meds and it is not uncommon for GPs to take on advice from a TI [trainee intern] med review. (Student 21)

I thought it was quite mundane when I made the review but once it came to going through it with the GP, it proved to be very useful. (Student 20)

Complexity of prescribing

Thirty-eight (79%) students said the medication review would change their prescribing practice. Themes from the comments regarding changes to prescribing practice revealed complex issues around prescribing that may not have been considered by students previously. Comments included deprescribing, more awareness of monitoring requirements, renal adjustment checking, familiarity with drug interactions, caution with high-risk drugs, checking what drugs patients are already on, documentation of prescribing reasons, and providing information to patients.

Being more cautious with prescribing meds when patients are already on a numerous amount of meds. (Student 10)

That patients are often on many meds that were started by different docs [doctors] and it can be tricky to know why and whether they are appropriate. (Student 8)

I learnt new things about what monitoring is needed for some drugs. I learnt that drug reconciliation can be really complicated, but very valuable. (Student 46)

Importance of monitoring

When reviewing the medication review assignments, the monitoring requirements section is inconsistently completed. The importance of monitoring was mentioned in 16 student survey results. Comments ranged from awareness of requirements for specific drugs, picking up on new medications and interactions, and focus on high-risk drugs,

The need to monitor medications and their effects not only when initiated but some also requiring regular monitoring. (Student 10)

The importance of reviewing medications even when there are no acute indications. How the appropriateness of medications can change with age + physiology eg renal function. (Student 22)

Two GP supervisors commented that they would now consider regular reviews of people on multiple medications.

I find that it has helped me think more carefully about certain medications, and why I use them. Regular reviews of people with polypharmacy. (GP Supervisor 2)

Value of resources

Resources used by the students when completing their medication reviews were both human interactions and written material. Seven of the GP supervisors recommended the pharmacist as a source of information and support. Alongside discussing the medication review with the GP supervisor, 38 (79%) students reported discussing the review with others. These others included the patient (20, 42%), pharmacist (11, 23%), student colleagues (12, 25%), nurse (8, 17%), another GP in the practice (11, 23%), and patient whānau (family) (4, 8%).

Discussing the case with a clinical pharmacist was extremely valuable. (Student 5)

Online resources mentioned included NZF,17 a medication list available to all health professionals (37, 79%), Best Practice Advocacy Centre (BPAC),18 a publication service for online medical information (28, 58%), 3D Health Pathways, an online platform for medical practitioner guidance on health conditions (13, 27%), internet and journal searches (12, 25%), and an evidence-based resource available at Uptodate.com (5, 10%). A few students mentioned deprescribing tools such as Medstopper (https://medstopper.com/).

Supervisor reflections on value to the student

GP supervisor comments were all positive on the value to students and patients. They also recognised the complexity of prescribing, with additional comments about knowing your patient, real-world experience, and enhancement of the overall approach to patients.

Student doctor was very knowledgeable but still there was room for guidance on a few points eg. where to write the classification of the medicine being taken. Also difference between strength (eg of tablet) and dose (actual amount taken each dose time). (GP Supervisor 8)

Challenging – time consuming but ultimately (if the GP trainer actively engages in the process) very useful. (GP Supervisor 4)

Useful process for understanding how the student is thinking. (GP Supervisor 9)

Discussion

Despite the significant amount of time taken by students and GP supervisors to complete a medication review, this study indicates that students and supervisors consider the activity valuable to themselves, each other, and patients.

Medication reviews have been encouraged and researched2024 more widely in recent years due to the increasing burden of polypharmacy across the globe and a desire to ensure medical and pharmacy students have the skills to be able to reflect on, and deal with, a complex array of medications.

Providing a safe environment for students to learn prescribing and deprescribing during their training is essential. Linton and Murdoch-Eaton24 describe 12 tips to facilitate medical student prescribing. Ten of the 12 steps are achieved with the described medication review activity including; start prescribing practice early, include dedicated time, routine access to formularies, prescribing in context, supervised prescribing, focus on high-risk medications, feedback on prescribing, involving the multidisciplinary team, using a range of teaching and learning strategies, embedding prescribing within students’ clinic consultation and practice, and including prescribing in assessments. The medication review activity does not require the student to write prescriptions, however, the general practice module does allow for students to practice prescribing and increases the number of prescriptions they write. Linton and Murdoch-Eaton24 also suggest the use of a student formulary which is not available in NZ.

The allocated time dedicated solely to considering prescribing practice, for both students and GP supervisors, is an unintended benefit of adding a medication review into student general practice placements. GP supervisors reflected that they do not have time to do a formalised medication review themselves, but that the work of the students provided beneficial patient care that they would otherwise be doing out of hours. Supervisors of students often feel that they provide all the learning opportunities. This study highlighted that the GP supervisors themselves learnt new things through the medication review assessment process and that the students were aware of their teaching role.

For students, the medication review is context specific, supervised, complex, and feedback25 driven. It gives an opportunity for the student to provide thoughts and ideas as much as the supervisor – modelling and enabling reflective practice for both participants.2628 The review also gives students the opportunity for exposure to the benefits of interprofessional collaboration with pharmacists, although this would be different in the different regions where students were placed. The added value to students was that while learning about a variety of medications they also felt they were contributing to the patient’s health and wellbeing and to their supervisor’s prescribing practice.

The medication review activity was implemented in response to a real-world problem, increasing polypharmacy. This study shows that deliberate structuring of learning activities that reflect on change to clinical practice can be successful and may have more benefit than initially anticipated. It is also hoped that the students will take this experience of managing polypharmacy into their postgraduate years, with improved understanding of the impacts on the patient and the general practice post hospital discharge. The concerns of the authors and comments by GP supervisors at regional workshops around time commitment of this activity appear to be counteracted by the perceived value that the activity provides.

Overall, the results of both surveys reflect the positive value sentiment expressed in previous verbal discussions with both students and GP supervisors.

Study strengths and limitations

This is one of the few studies reviewing learning experiences of a medication review from both medical students’ and GP supervisors’ perspectives.

This cohort study was conducted during the first year of the COVID-19 pandemic.

A limitation of this study is that we did not determine prior student teaching experiences regarding deprescribing and polypharmacy, although from comments received from the students there appears to have been little prior exposure to deprescribing teaching and learning opportunities.

Conclusion

Medication prescribing and deprescribing are core activities within medical practice. Explicitly learning about deprescribing is important for any prescriber. The results of this study show that a medication review process undertaken by final year medical students, reflecting on polypharmacy, provides significant additional prescribing and deprescribing practice learning and other benefits to students, GP supervisors, and their patients.

Supplementary material

Supplementary material is available online.

Data availability

The data that support this study cannot be publicly shared due to ethical or privacy reasons and may be shared upon reasonable request to the corresponding author if appropriate.

Conflicts of interest

The authors declare no conflicts of interest.

Declaration of funding

This research did not receive any specific funding.

Acknowledgements

We sincerely thank the students and GP supervisors (and indirectly their patients) who participated in this study and the medication review tutors who mark the reviews and provide valuable feedback to the students. We also acknowledge the wider primary care team who are often involved in these reviews.

References

Health and Disability Commissioner. Complaints Closed by the Health and Disability Commissioner about Medication Errors: Analysis and Report 2009–2016. Wellington: Health and Disability Commissioner; 2018.

Lillis S, Lord H. Repeat prescribing–reducing errors. J Prim Health Care 2011; 3(2): 153-158.
| Crossref | Google Scholar |

Medical Council of New Zealand. Good Prescribing practice. Wellington: Medical Council of New Zealand; 2020. Available at https://www.mcnz.org.nz/assets/standards/ceae513c85/Statement-on-good-prescribing-practice.pdf

Leitch S, Dovey SM, Cunningham WK, et al. Medication-related harm in New Zealand general practice: a retrospective records review. Br J Gen Pract 2021; 71(709): e626-e633.
| Crossref | Google Scholar | PubMed |

Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377-384.
| Crossref | Google Scholar | PubMed |

Garfield S, Barber N, Walley P, et al. Quality of medication use in primary care — mapping the problem, working to a solution: a systematic review of the literature. BMC Med. 2009; 7: 50-58.
| Crossref | Google Scholar | PubMed |

Roughead EE, Semple SJ. Medication safety in acute care in Australia: where are we now? Part I: A review of the extent and causes of medication problems 2002–2008. Aust N Z Health Policy 2009; 6: 18.
| Crossref | Google Scholar | PubMed |

Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation; making it safe and sound. London: The Kings Fund; 2013.

World Health Organization. Medication without harm: WHO global patient safety challenge. Geneva: World Health Organization; 2017. Available at https://www.who.int/initiatives/medication-without-harm

10  Budnitz DS, Lovegrove MC, Shehab N, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365(21): 2002-12.
| Crossref | Google Scholar | PubMed |

11  World Health Organization. Medication safety in polypharmacy: Technical report. Geneva: World Health Organization; 2019.

12  Goldberg R, Mabee J, Chan L, et al. Drug–drug and drug–disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 1996; 14: 447-450.
| Crossref | Google Scholar | PubMed |

13  Lillis S, Macklin N, Thorn M, et al. Repeat prescribing safety survey. J Prim Health Care 2019; 11(3): 243-248.
| Crossref | Google Scholar | PubMed |

14  Jubraj B, Marvin V, Poots AJ, et al. A pilot survey of junior doctors’ attitudes and awareness around medication review: time to change our educational approach? Eur J Hosp Pharm Sci Pract 2015; 22(4): 243-248.
| Crossref | Google Scholar | PubMed |

15  Otago Medical School. Curriculum Map: Core therapeutics: medicines: pharmacotherapy and quality use of medicines. Dunedin: University of Otago; 2020. Available at https://medmap.otago.ac.nz/ui/outcomesets/537

16  Health Quality and Safety Commission New Zealand. Atlas of Healthcare Variation: Primary Health Organisation Analyses: Polypharmacy. Wellington: Health Quality and Safety Commission; 2019. Available at https://public.tableau.com/app/profile/hqi2803/viz/Polypharmacysinglemap/AtlasofhealthcarevariationPolypharmacy?publish=yes

17  New Zealand Formulary. New Zealand Formulary v141. New Zealand: New Zealand Formularly; 2024. Available at http://nzformulary.org/

18  Best Practice Advocacy Centre New Zealand (BPACNZ). Best Practice Advocacy Centre better medicine. New Zealand: BPACNZ; 2024. Available at https://bpac.org.nz/

19  Thompson J. A guide to abductive thematic analysis. Qual Rep 2022; 27(5): 1410-1421.
| Crossref | Google Scholar |

20  Basheti IA, Qunaibi EA, Aburuz S, et al. Home medication review in a patient care experience for undergraduate pharmacy students. Am J Pharm Educ 2013; 77(8): 173.
| Crossref | Google Scholar | PubMed |

21  Kaae S, Sørensen EW, Nørgaard LS. Evaluation of Danish pharmacist student-physician medication review collaboration model. Int J Cin Pharm 2014; 36: 615-622.
| Crossref | Google Scholar | PubMed |

22  Poots AJ, Jubraj B, Ward E, et al. Education around medication review and deprescribing: a survey of medical students’ perspectives. Ther Adv Drug Safety 2020; 11: 2042098620909610.
| Crossref | Google Scholar |

23  Heaton A, Webb DJ, Maxwell SRJ. Undergraduate preparation for prescribing: the views of 2413 UK medical students and recent graduates. Br J Clin Pharmacol 2008; 66(1): 128-134.
| Crossref | Google Scholar | PubMed |

24  Linton KD, Murdoch-Eaton D. Twelve tips for facilitating medical students prescribing learning on clinical placement. Med Teach 2020; 42(10): 1134-1139.
| Crossref | Google Scholar | PubMed |

25  Kolb AY, Kolb DA. Learning styles and learning spaces: enhancing experiential learning in higher education. Acad Manag Learn Educ 2005; 4(2): 193-212.
| Crossref | Google Scholar |

26  Schon DA. The reflective practitioner: how professionals think in action. New York: Basic Books; 1983

27  Moon JA Reflection in learning and professional development: theory and practice. London: Routledge; 2004

28  Mickleborough T. Intuition in medical practice: a reflection on Donald Schon’s reflective practitioner. Med Teach 2015; 37: 889-891.
| Crossref | Google Scholar | PubMed |